PTC Therapeutics PTCT Business Segments — Other Expense Segment Net

Similar metrics at other companies

DCILife Sciences Segment — Other segment items

$27.5M+20.6%

DCILife Sciences Segment — Net Sales

$83.5M+12.5%

IIPRLife Science Portfolio Segment: — Net Income

$5.54M—

DCILife Sciences Segment — Goodwill

$172.8M+2.2%

RVTYLife Sciences — Segment revenue

$361.85M+6.3%

TMOLife Sciences Solutions — Other segment items

$50M+11.1%

FAQ

What is PTC Therapeutics's business segments — other expense segment net?

PTC Therapeutics (PTCT) reported business segments — other expense segment net of $43.13M in Q1 2026.

How has PTC Therapeutics's business segments — other expense segment net changed year-over-year?

PTC Therapeutics's business segments — other expense segment net increased by 5.7% year-over-year, from $40.81M to $43.13M.

What is the long-term trend for PTC Therapeutics's business segments — other expense segment net?

Over 2 years (2023 to 2025), PTC Therapeutics's business segments — other expense segment net has grown at a -38.5% compound annual growth rate (CAGR), from $418.5M to $158.46M.

What does business segments — other expense segment net mean?

This metric aggregates miscellaneous costs and non-recurring charges that do not fall into standard operating expense categories for the Life Science segment. It provides visibility into peripheral financial outflows that impact the segment's net contribution. Monitoring this helps identify hidden operational inefficiencies or one-time events that affect the segment's bottom-line performance.